ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

HOWL Werewolf Therapeutics Inc

5.48
-0.24 (-4.20%)
2024年5月9日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Werewolf Therapeutics Inc HOWL NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.24 -4.20% 5.48 06:09:51
始値 安値 高値 終値 前日終値
5.72 5.39 5.84 5.48 5.72
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0320:00GLOBEWerewolf Therapeutics Reports First Quarter 2024 Financial..
2024/4/2423:05GLOBEWerewolf Therapeutics Announces WTX-124 Clinical Abstract..
2024/4/2321:00GLOBEWerewolf Therapeutics Presents First Preclinical Data..
2024/4/0605:30GLOBEWerewolf Therapeutics Presents Preclinical Results..
2024/4/0505:30GLOBEWerewolf Therapeutics to Present First-of-Its-Kind Data..
2024/3/0721:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0721:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0721:11EDGAR2Form 8-K - Current report
2024/3/0721:00GLOBEWerewolf Therapeutics Reports Fourth Quarter and Full Year..
2024/3/0622:00GLOBEWerewolf Therapeutics to Present at the 2024 Leerink..
2024/3/0606:30GLOBEWerewolf Therapeutics Announces Upcoming Presentations at..
2024/2/1006:39EDGAR2Form 8-K - Current report
2024/2/1006:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/0822:08EDGAR2Form 8-K - Current report
2024/1/0509:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0509:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0507:00EDGAR2Form 8-K - Current report
2024/1/0506:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:05GLOBEWerewolf Therapeutics Appoints Michael Atkins, M.D., to its..
2023/11/2221:00GLOBEWerewolf Therapeutics to Present at the Evercore ISI..
2023/11/1506:34EDGAR2Form 8-K - Current report
2023/11/1506:25GLOBEWerewolf Therapeutics Reports Third Quarter 2023 Financial..
2023/11/0320:05EDGAR2Form 8-K - Current report
2023/11/0320:00GLOBEWerewolf Therapeutics Presents Preliminary Monotherapy Data..
2023/10/3122:00GLOBEWerewolf Therapeutics to Present Clinical and Preclinical..
2023/9/2722:00GLOBEWerewolf Therapeutics Announces Upcoming Presentations at..
2023/9/1820:00EDGAR2Form 8-K - Current report
2023/9/1205:05GLOBEWerewolf Therapeutics to Host KOL Event Highlighting IL-2..
2023/9/0605:05GLOBEWerewolf Therapeutics to Participate in Upcoming Investor..
2023/8/2503:00APSBiotech Soars On New Price Target And Analyst Rating
2023/8/1020:16EDGAR2Form 8-K - Current report
2023/8/1020:10GLOBEWerewolf Therapeutics Reports Second Quarter 2023 Financial..
2023/8/1020:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/6/0120:00GLOBEWerewolf Therapeutics to Present at the Jefferies Healthcare..
2023/5/1120:00GLOBEWerewolf Therapeutics Reports First Quarter 2023 Financial..

最近閲覧した銘柄

Delayed Upgrade Clock